Antiretroviral therapy optimisation without genotype resistance testing: a perspective on treatment history based models (Q33741902)

29 July 2017

title

Antiretroviral therapy optimisation without genotype resistance testing: a perspective on treatment history based models (English)

1 reference

29 July 2017

main subject

anti-retroviral agent

0 references

Anne-Mieke Vandamme

0 references

Simona Di Giambenedetto

object named as

Simona Di Giambenedetto

1 reference

29 July 2017

André Altmann

0 references

Maurizio Zazzi

0 references

Anders Sönnerborg

1 reference

29 July 2017

Rolf Kaiser

1 reference

David A. M. C. van de Vijver

29 July 2017

object named as

David A van de Vijver

1 reference

29 July 2017

Mattia C F Prosperi

1 reference

29 July 2017

Michal Rosen-Zvi

1 reference

29 July 2017

Eugen Schülter

1 reference

29 July 2017

Daniel Struck

1 reference

29 July 2017

Peter Sloot

1 reference

29 July 2017

EuResist study group

1 reference

29 July 2017

Virolab study group

1 reference

29 July 2017

language of work or name

English

0 references

publication date

29 October 2010

1 reference

29 July 2017

1 reference

29 July 2017

1 reference

29 July 2017

1 reference

29 July 2017

page(s)

e13753

1 reference

Creative Commons Attribution 4.0 International

29 July 2017

start time

29 October 2010

1 reference

April 2022 Public Data File from Crossref

copyrighted

0 references

cites work

Antiretroviral treatment of adult HIV infection: 2010 recommendations of the International AIDS Society-USA panel

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2966424

Modelling response to HIV therapy without a genotype: an argument for viral load monitoring in resource-limited settings

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2966424

Low-abundance HIV drug-resistant viral variants in treatment-experienced persons correlate with historical antiretroviral use

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2966424

Virological monitoring and resistance to first-line highly active antiretroviral therapy in adults infected with HIV-1 treated under WHO guidelines: a systematic review and meta-analysis

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2966424

Advances and future directions in HIV surveillance in low- and middle-income countries

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2966424

A comparison of three computational modelling methods for the prediction of virological response to combination HIV therapy

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2966424

Historical resistance profile helps to predict salvage failure.

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2966424

Resistance and viral subtypes: how important are the differences and why do they occur?

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2966424

Electronic medical record systems, data quality and loss to follow-up: survey of antiretroviral therapy programmes in resource-limited settings

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2966424

Long-term immunologic response to antiretroviral therapy in low-income countries: a collaborative analysis of prospective studies

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2966424

Comparison of classifier fusion methods for predicting response to anti HIV-1 therapy

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2966424

Optimization of the oligonucleotide ligation assay, a rapid and inexpensive test for detection of HIV-1 drug resistance mutations, for non-North American variants

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2966424

Selecting anti-HIV therapies based on a variety of genomic and clinical factors

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2966424

Second-line combination antiretroviral therapy in resource-limited settings: facing the challenges through clinical research

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2966424

HIV drug resistance surveillance for prioritizing treatment in resource-limited settings

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2966424

HIV resistance and the developing world

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2966424

Interpreting resistance data for HIV-1 therapy management--know the limitations

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2966424

Web resources for HIV type 1 genotypic-resistance test interpretation

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2966424

A new model to monitor the virological efficacy of antiretroviral treatment in resource-poor countries

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2966424

Clinically validated genotype analysis: guiding principles and statistical concerns.

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2966424

The WHO public-health approach to antiretroviral treatment against HIV in resource-limited settings

21 June 2018

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0013753

The cost effectiveness of antiretroviral treatment strategies in resource-limited settings

21 January 2018

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0013753

Evaluation of two commercially available alternatives for HIV-1 viral load testing in resource-limited settings

21 January 2018

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0013753

SMARThivPack: a complexity free and cost effective "three tests" combo kit model for improving HIV patients monitoring standards in resource poor settings

21 January 2018

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0013753

A randomized study of antiretroviral management based on plasma genotypic antiretroviral resistance testing in patients failing therapy. CPCRA 046 Study Team for the Terry Beirn Community Programs for Clinical Research on AIDS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0013753

Drug-resistance genotyping in HIV-1 therapy: the VIRADAPT randomised controlled trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0013753

Retrospective analysis of antiretroviral HIV treatment success based on medical history or guided by the reverse hybridisation LiPA HIV genotyping system

21 January 2018

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0013753

Estimation of an in vivo fitness landscape experienced by HIV-1 under drug selective pressure useful for prediction of drug resistance evolution during treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0013753

Initiatives for developing and comparing genotype interpretation systems: external validation of existing rule-based interpretation systems for abacavir against virological response

21 January 2018

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0013753

An introduction to ROC analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0013753

Predicting the response to combination antiretroviral therapy: retrospective validation of geno2pheno-THEO on a large clinical database

21 January 2018

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0013753

Minority quasispecies of drug-resistant HIV-1 that lead to early therapy failure in treatment-naive and -adherent patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0013753

HIV-1 drug resistance: degree of underestimation by a cross-sectional versus a longitudinal testing approach

21 January 2018

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0013753

Performance of Immunologic Responses in Predicting Viral Load Suppression

21 January 2018

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0013753

Investigation of expert rule bases, logistic regression, and non-linear machine learning techniques for predicting response to antiretroviral treatment.

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2966424

The development of artificial neural networks to predict virological response to combination HIV therapy.

30 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2966424

Improved prediction of response to antiretroviral combination therapy using the genetic barrier to drug resistance

30 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2966424

Evaluation of the Abbott Real-Time HIV-1 quantitative assay with dried blood spot specimens

30 October 2018

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0013753

HIV drug resistance and implications for the introduction of antiretroviral therapy in resource-poor countries

21 January 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/21060792

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Three-year clinical outcomes of resistance genotyping and expert advice: extended follow-up of the Argenta trial

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/21060792

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1371/JOURNAL.PONE.0013753

1 reference

29 July 2017

0 references

1 reference

29 July 2017

1 reference